CTLA4 and cancer: CTLA4 acts as a negative regulator of T cells involved in antitumor immune responses, and its blockade can enhance immune responses and repel tumors; it has beenhypothesized that CTLA4 may reduce antitumor responses and increase the risk of cancer by raising the T cell activation threshold in the early stages of tumorigenesis [ 9].